Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma Meeting Abstract


Authors: Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; Pietzak, E. J.
Abstract Title: Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
Meeting Title: 2022 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 6 Suppl.
Meeting Dates: 2022 Feb 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-02-20
Language: English
ACCESSION: WOS:000771008900574
DOI: 10.1200/JCO.2022.40.6_suppl.567
PROVIDER: wos
Notes: Meeting Abstract: 567 -- Meeting was conducted online as well as in person -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Guido Dalbagni
    325 Dalbagni
  2. David Solit
    779 Solit
  3. Gopakumar Vasudeva Iyer
    342 Iyer
  4. Bernard Bochner
    468 Bochner
  5. Eugene J Pietzak
    116 Pietzak
  6. Alvin Chun chin Goh
    72 Goh
  7. Song Jiang
    5 Jiang
  8. Wesley Yip
    12 Yip